Yatharth Hospital & Trauma Care Services Limited held its 1st/2026-27 Extra-Ordinary General Meeting (EGM) on October 15, 2026, at 11:00 am IST through Video Conferencing and Other Audio-Visual Means (VC/OAVM).

The meeting was convened in compliance with the Companies Act, 2013, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dr. Ajay Kumar Tyagi, Chairman and Whole-time Director, presided over the session.

Quorum and attendance details

The Company Secretary confirmed that the requisite quorum was present at the commencement of proceedings. The total number of members as of the cut-off date, October 8, 2026, stood at 101,829. During the virtual meeting, a total of 74 members participated, comprising four from the promoter group and 70 from the public category.

Board participation and procedure

The Board of Directors present during the meeting included:

1. Dr. Ajay Kumar Tyagi, Chairman and Whole-time Director
2. Dr. Kapil Kumar, Managing Director

The Company Secretary outlined the procedures for convening the EGM through VC/OAVM and detailed the voting mechanisms available to members. This included remote e-voting prior to the meeting and e-voting during the session for members who had not cast their votes electronically.

The disclosure regarding the outcome of the EGM was submitted to both the National Stock Exchange of India Limited and BSE Limited under Regulation 30 of the SEBI LODR Regulations. The proceedings summary is also accessible on the company's investor relations webpage.

Yatharth Hospital & Trauma Care Services Limited has announced the closure of its trading window for dealing in company securities, effective October 1, 2026. This measure is taken in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct.

The restriction applies to all designated persons and their immediate relatives. The trading window will remain closed until 48 hours after the declaration of the unaudited financial results for the second quarter and half year ending September 30, 2026. The company stated that all designated persons have already been informed of this development.

Regulatory Compliance and Timeline

The closure is a standard procedural requirement to prevent insider trading during the sensitive period preceding the announcement of financial performance. The specific dates and regulatory framework are outlined below:

The date of the Board Meeting scheduled to approve these financial results will be intimated in due course. Investors and market participants should note that the reopening of the trading window is strictly tied to the public disclosure of the quarterly earnings.

Corporate Governance Context

This action reflects the company's adherence to corporate governance norms mandated by Indian securities regulators. By restricting trading activity among insiders, the company aims to ensure a level playing field for all investors during the pre-announcement phase. The disclosure regarding the trading window closure is available on the company's investor relations webpage for public record.